Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FDA approval brings first gene therapy to the United States
Thursday, August 31, 2017The US Food and Drug Administration issued a historic action today making the first gene therapy available in the United States ushering in a new approach to the treatment of cancer and other serious and lifethreatening diseases The FDA approved K...
Labcyte and SEngine Precision Medicine Collaborate to Offer Functional Drug Screening for Oncology
Thursday, August 31, 2017Labcyte Inc and SEngine Precision Medicine today announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcytes advanced acoustic liquid handling solutions with SEngines unique functional drug testing...
Alimera Sciences Signs Agreement for Exclusive Distributor of ILUVIEN® in France
Wednesday, August 30, 2017Alimera Sciences Inc a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals today announced that Alimera Sciences Limited its European subsidiary based in the United Kingdom has s...
Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products
Wednesday, August 30, 2017Jazz Pharmaceuticals plc and ImmunoGen Inctoday announced that the companies have entered into a collaboration and option agreement granting Jazz Pharmaceuticals exclusive worldwide rights to opt into development and commercialization of two earlysta...
Gilead Sciences to Acquire Kite Pharma for $11.9 Billion
Tuesday, August 29, 2017Gilead Sciences Inc and Kite Pharma Inc announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Kite for per share in cash The transaction which values Kite at approximately billion was unanimousl...
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals
Tuesday, August 29, 2017Daiichi Sankyo Company Limited and Boston Pharmaceuticals Inc today announced they have entered into a worldwide licensing agreement for Daiichi Sankyos novel RET inhibitor DS DS is a highly selective and potent RET ret protooncogene kinase inhibi...
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
Monday, August 28, 2017Genentech a member of the Roche Group announced today that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA and granted Priority Review for Gazyva obinutuzumab in combination with chemo...
Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™
Monday, August 28, 2017Kedrion Biopharma and Kamada Ltd two leading humanderived protein therapeutics companies today announced that KEDRAB rabies immune globulin Human has received US Food and Drug Administration FDA approval for passive transient postexposure prophylaxis...
Theragnostics Announces Partnership with ROTOP and Establishes U.S. Headquarters
Thursday, August 24, 2017Theragnostics Ltd a radiopharmaceuticals company developing products for the diagnosis and treatment of cancer announced a mutual distribution and manufacturing agreement with ROTOP Pharmaka GmbH covering select products in the Companies respective m...
Chugai's Emicizumab Receives Priority Review Designation by FDA for Hemophilia A with Inhibitors
Thursday, August 24, 2017Chugai Pharmaceutical Co Ltd announced that the US Food and Drugs Administration FDA has accepted the Biologics License Application BLA and has granted Priority Review for an investigational antibody emicizumab prophylaxis preventative as a onceweekl...
